You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 291 No. 18, May 12, 2004 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Medical Practice
 •Medical Ethics
 •Complementary and Alternative Medicine
 •Statistics and Research Methods
 •Randomized Controlled Trial
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Ethical Issues in Research in Complementary and Alternative Medicine

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: We agree with Dr Miller and colleagues1 that any therapy should be evaluated by the most rigorous and feasible methods possible. We do not entirely agree, however, with their assertion that therapies might be considered legitimate entirely by virtue of their placebo effect. The authors argued that the basis of using placebo controls has to do with demonstrating risk-benefit ratio. In fact, the primary reason for using placebo controls has to do with establishing a specific causal relationship between a therapy and outcome; ie, whether an intervention has scientific veracity. Placebo controls account for other factors that influence outcomes.

It remains unclear exactly which factors contribute to a placebo effect2 or even whether placebos have any significant clinical effects.3 With more evidence, it might be ethically appropriate to combine any identifiable placebogenic factors with already proven specific therapies. This would mean using factors that promote nonspecific healing . . . [Full Text of this Article]

Ted J. Kaptchuk, OMD
ted.kaptchuk@hms.harvard.edu
Osher Institute
Harvard Medical School

Anthony Lembo, MD
Beth Israel Deaconess Medical Center
Boston, Mass



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Ethical Issues in Research in Complementary and Alternative Medicine
Harvey E. Cantor and Anup Malani
JAMA. 2004;291(18):2192.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Wayne B. Jonas, Christine Goertz, John Ives, Ronald A. Chez, and Harald Walach
JAMA. 2004;291(18):2192.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Matko Marusic
JAMA. 2004;291(18):2193.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine
Paul J. Millea
JAMA. 2004;291(18):2193.
EXTRACT | FULL TEXT  

Ethical Issues in Research in Complementary and Alternative Medicine—Reply
Franklin G. Miller, Ezekiel J. Emanuel, Donald L. Rosenstein, and Stephen E. Straus
JAMA. 2004;291(18):2193-2194.
EXTRACT | FULL TEXT  

Ethical Issues Concerning Research in Complementary and Alternative Medicine
Franklin G. Miller, Ezekiel J. Emanuel, Donald L. Rosenstein, and Stephen E. Straus
JAMA. 2004;291(5):599-604.
ABSTRACT | FULL TEXT  






HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2004 American Medical Association. All Rights Reserved.